# Biomarin Pharmaceutical Inc. (BMRN) — Gross Profit

## Annual Gross Profit (USD)

| Year | Gross Profit |
| --- | --- |
| 2025 | $2.50B |
| 2024 | $2.27B |
| 2023 | $1.89B |
| 2022 | $1.59B |
| 2021 | $1.38B |
| 2020 | $1.34B |
| 2019 | $1.34B |
| 2018 | $1.18B |
| 2017 | $1.07B |
| 2016 | $907M |
| 2015 | $738M |
| 2014 | $627M |
| 2013 | $460M |
| 2012 | $409M |
| 2011 | $357M |
| 2010 | $306M |
| 2009 | $259M |
| 2008 | $244M |

## Quarterly Gross Profit (USD)

| Quarter | Gross Profit |
| --- | --- |
| 2026-03-31 | $571M |
| 2025-09-30 | $636M |
| 2025-06-30 | $675M |
| 2025-03-31 | $594M |
| 2024-09-30 | $557M |
| 2024-06-30 | $582M |
| 2024-03-31 | $524M |
| 2023-09-30 | $453M |
| 2023-06-30 | $465M |
| 2023-03-31 | $461M |
| 2022-09-30 | $389M |
| 2022-06-30 | $411M |
| 2022-03-31 | $402M |
| 2021-09-30 | $305M |
| 2021-06-30 | $375M |
| 2021-03-31 | $366M |
| 2020-09-30 | $288M |
| 2020-06-30 | $332M |
| 2020-03-31 | $391M |
| 2019-09-30 | $364M |
| 2019-06-30 | $310M |
| 2019-03-31 | $312M |
| 2018-09-30 | $313M |
| 2018-06-30 | $294M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BMRN/gross-profit)